Company / SG&A Expense
Agilent Technologies SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$1.7B
FY2025
5-year range
$1.5B / $1.7B
FY2021-FY2025
Trend
+9.0%
vs FY2024
Sector context
#31 of 158
Health Care
What the data says
Agilent Technologies's sg&a expense of $1.7B is higher than 80% of companies in the Health Care sector (FY2025). SG&A Expense has fluctuated over the past 10 years, ranging from $1.2B in FY2017 to $1.7B in FY2025.
Based on SEC 10-K filings.
$1.7B in FY2025 with a 5-year CAGR of +4.2%. Top quartile in the Health Care sector.
Increased from $1.6B to $1.7B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +4.5%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 158This company $1.7B Sector average $175.9B
▼
-99.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 9.0% year-over-year.
- Ranks #31 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2017.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7B | +9.0% |
| FY2024 | $1.6B | -3.2% |
| FY2023 | $1.6B | +8.2% |
| FY2022 | $1.5B | +2.5% |
| FY2021 | $1.5B | +5.1% |
| FY2020 | $1.4B | -4.9% |
| FY2019 | $1.5B | +16.5% |
| FY2018 | $1.3B | +5.4% |
| FY2017 | $1.2B | -5.1% |
| FY2016 | $1.3B | +5.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026